Skip to content | Change text size
 

Suzanne M. Caliph

Lecturer in Pharmaceutics

photo of Suzanne M. Caliph, Senior Lecturer in Pharmaceutics

B.Pharm, MPharmSci (Monash Univ), GCHE (Monash Univ), MPS.

Phone: +61 3 990 39682
Fax: +61 3 990 39583
Email: suzanne.caliph@pharm.monash.edu.au

General research interests

  • Drug delivery to the lymphatic system
  • Oral bioavailability, distribution and clearance of lipophilic compounds 
  • On-line assisted teaching and learning in Pharmaceutics

Significant publications

  1. S.M. Caliph, W.A. Faassen, G.M. Vogel, C.J.H. Porter. The role of lymphatic transport in the oral bioavailability of two highly lipophilic immunomodular compounds after administration in a lipid based formulation. (2006) Proceedings of APSA - Australasian Pharmaceutical Sciences Association, 85.
  2. K. Jones, I.C. Larson, D. Weaver, S.M. Caliph. The adventures of Trev the tablet: Replacing practical classes and lectures using an online game scenario (2005) Australasian Journal of Educational Technology (ASCILITE), 309-312.
  3. S.M. Caliph, W.N. Charman and C.J.H. Porter.  Systemic exposure of a model lipophilic drug is changed when drug enters the circulation in association with lymph as opposed to plasma (2004) Proceedings of Australasian Pharmaceutical Sciences Association,  47, 104.
  4. S.M. Caliph and A. Onsman. A Review of outsourced sterile dispensing learning activities. (2003) Proceedings of Australasian Pharmaceutical Sciences Association, 88, 132.
  5. G.A. Edwards, C.J.H. Porter, S.M.Caliph, S-M. Khoo and W.N. Charman. Animal models for the study of intestinal lymphatic drug transport. (2001) Advanced Drug Deliv Review, 50(1-2), 45-60.
  6. S.M.Caliph, W.N. Charman and C.J.H. Porter. Effect of short, medium, and long-chain fatty acid based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balance in lymph-cannulated and non-cannulated rats. (2000) J.Pharm.Sci., 89(8), 1073-1084.
  7. S.M Caliph, W.N. Charman and C.J.H Porter. The bioavailability of a highly lipophilic compound after oral administration in lipidic and lipid free formulations: Assessment in lymph fistulated and non-lymph fistulated rat models. (1998)  Proceedings of Australasian Society of Clinical and Experimental Pharmacology and Toxicology and the Australasian Pharmaceutical Sciences Association, O14.4, 63.
  8. S.M. Caliph, W. N. Charman and C.J.H. Porter. The effect of medium and long chain lipids on the lymphatic transport and bioavailability of halofantrine, a highly lipophilic drug, after oral administration to conscious rats. (1997) Proceedings of Australasian Pharmaceutical Sciences Association, 19, 53.
  9. C.J.H. Porter, S.M. Caliph, and W.N. Charman. Differences in pre- and post-prandial plasma lipid profiles affect the extraction efficiency of a model highly lipophilic drug from plasma. (1997)J.Pharm.Biomed.Anal., 16(1): 175-180.
  10. S.M. Caliph, W.N. Charman and C.J.H. Porter. Differences in plasma lipid profiles affect the extraction efficiency of a model highly lipophilic drug from plasma. (1996) Australian Journal of Hospital Pharmacy (Supp), 26.